David R. Gastfriend, MD, has joined the Treatment Research Institute (TRI) as a senior adviser; he has worked at pharmaceutical company Alkermes Inc. since 2005.
David R. Gastfriend, MD, has joined the Treatment Research Institute (TRI) as a senior adviser; he has worked at pharmaceutical company Alkermes Inc. since 2005.
David R. Gastfriend, MD, has...